Erwin P Bottinger, MD

Director and Professor
Icahn School of Medicine at Mount Sinai
The Charles Bronfman Institute for Personalized Medicine

Biographical Sketch:
Dr. Böttinger is a native of Germany where he obtained his M.D. degree from the University of Erlangen-Nuremberg in 1986. He trained in internal medicine and nephrology in the United States, including a Clinical and Research Fellowship in Nephrology at the Massachusetts General Hospital and Harvard Medical School. After additional research training at the National Cancer Institute, Bethesda, Dr. Bottinger joined the faculty at the Albert Einstein College of Medicine where he served as Director of the Albert Einstein Biotechnology Center. In 2004, he was recruited to the Mount Sinai School of Medicine in New York City where he currently holds an endowed chair as Irene and Dr. Arthur Fishberg Professor in Medicine. Dr. Bottinger served as Vice Chairman for Biomedical Research in the Department of Medicine, before he was appointed in 2007 as inaugural Director of The Charles Bronfman Institute for Personalized Medicine at Mount Sinai, an interdisciplinary institute to advance personalized health and healthcare. Dr. Bottinger’s laboratory research is focused on early pathomechanisms and biomarkers in diabetic nephropathy and non-diabetic kidney diseases. His research laboratory has been continuously funded with R01 research grants from the National Institutes of Health since 1998. Dr. Böttinger is the Principal Investigator of Mount Sinai’s BioMe hospital-based Biobank and several NIH-funded national research consortia, including the Chronic Kidney Disease Biomarker Consortium and the electronic medical records and genomics (eMERGE) network.
S39 Reducing Health Disparities Through Clinical Trials
S39-3 e-Trials and Community-Based Research